PerformanceRiskValuationProfitabilityCashflowLiquidityESGRevenue & Geographic ExposureForecastFinancial GrowthIncome GrowthCashflow GrowthBalance Sheet Growth
1536.00 - 1565.00
1090.00 - 1784.00
46.2K / 155.6K (Avg.)
23.48 | 66.41
Steady, sustainable growth is a hallmark of high-quality businesses. Value investors watch these metrics to confirm that the company's fundamental performance aligns with—or outpaces—its current market valuation.
54.18%
Revenue growth above 1.5x 6617.T's 16.13%. David Dodd would confirm if the firm has a unique advantage driving sales higher.
46.39%
Gross profit growth 1.25-1.5x 6617.T's 31.15%. Bruce Berkowitz would see if strategic sourcing or brand premium explains outperformance.
84.64%
EBIT growth below 50% of 6617.T's 515.44%. Michael Burry would suspect deeper competitive or cost structure issues.
62.55%
Operating income growth under 50% of 6617.T's 426.04%. Michael Burry would be concerned about deeper cost or sales issues.
70.19%
Net income growth under 50% of 6617.T's 2831.43%. Michael Burry would suspect the firm is falling well behind a key competitor.
70.18%
EPS growth under 50% of 6617.T's 2830.41%. Michael Burry would suspect deeper structural issues or share dilution limiting per-share gains.
70.18%
Diluted EPS growth under 50% of 6617.T's 2830.41%. Michael Burry would worry about an eroding competitive position or excessive dilution.
-0.00%
Share reduction while 6617.T is at 0.02%. Joel Greenblatt would see if the company has a better buyback policy than the competitor.
-0.00%
Reduced diluted shares while 6617.T is at 0.02%. Joel Greenblatt would see a relative advantage if the competitor is diluting more.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
20.46%
10Y CAGR of 20.46% while 6617.T is zero. Bruce Berkowitz would see if incremental growth can widen into a significant edge.
1.20%
Positive 5Y CAGR while 6617.T is negative. John Neff might see an underappreciated edge for the firm vs. the competitor.
-10.83%
Negative 3Y CAGR while 6617.T stands at 11.49%. Joel Greenblatt would look for missteps or fading competitiveness that hurt sales.
100.00%
OCF/share CAGR of 100.00% while 6617.T is zero. Bruce Berkowitz might see a slight advantage that could compound over time.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
-214.80%
Negative 10Y net income/share CAGR while 6617.T is at 0.00%. Joel Greenblatt sees a major red flag in long-term profit erosion.
-184.42%
Negative 5Y net income/share CAGR while 6617.T is 7.22%. Joel Greenblatt would see fundamental missteps limiting profitability vs. the competitor.
-167.39%
Negative 3Y CAGR while 6617.T is 189.04%. Joel Greenblatt might call for a short-term turnaround strategy or cost realignment.
363.18%
10Y equity/share CAGR above 1.5x 6617.T's 1.58%. David Dodd would confirm if consistent earnings retention or fewer write-downs drive this advantage.
45.89%
5Y equity/share CAGR above 1.5x 6617.T's 4.73%. David Dodd might see stronger earnings retention or fewer asset impairments fueling growth.
13.94%
3Y equity/share CAGR above 1.5x 6617.T's 2.16%. David Dodd verifies the company’s short-term capital management far exceeds the competitor’s pace.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
-3.03%
Firm’s AR is declining while 6617.T shows 10.80%. Joel Greenblatt sees stronger working capital efficiency if sales hold up.
4.92%
We show growth while 6617.T is shrinking stock. John Neff wonders if the competitor is more disciplined or has weaker demand expectations.
4.17%
Asset growth at 50-75% of 6617.T's 5.79%. Martin Whitman questions if the firm is lagging expansions or if the competitor invests more aggressively.
-0.05%
We have a declining book value while 6617.T shows 1.46%. Joel Greenblatt sees a fundamental disadvantage in net worth creation vs. the competitor.
4.90%
Debt shrinking faster vs. 6617.T's 54.74%. David Dodd sees a safer balance sheet if it doesn't impair future growth.
12.70%
R&D growth of 12.70% while 6617.T is zero. Bruce Berkowitz checks if the moderate investment leads to meaningful product differentiation.
3.92%
SG&A growth well above 6617.T's 1.90%. Michael Burry sees potential margin erosion unless it translates into higher sales or brand equity.